Alignment Healthcare insider plans sale of 22,500 shares

Alignment Healthcare, Inc. filed a notice of proposed sale of 22,500 shares of its common stock under Rule 144.

Accepted by SEC EDGAR 02/09/2026 - 03:55 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Alignment Healthcare, Inc. filed a notice of proposed sale of 22,500 shares of its common stock under Rule 144. The planned sale through E-Trade Finance has an aggregate market value of $489,375 and is targeted for around February 10, 2026 on the Nasdaq Stock Market.

The seller previously acquired 38,941 common shares on February 7, 2024 as a stock award under the company’s 2021 Equity Incentive Plan. Shares outstanding were 200,091,742 at the time referenced, providing context for the scale of the planned sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Alignment Healthcare (ALHC) shares are covered by the latest Rule 144 notice?

The notice covers a proposed sale of 22,500 shares of common stock. These shares are planned to be sold through E-Trade Finance under Rule 144, giving advance public disclosure of an intended secondary market transaction.

What is the aggregate market value of the Alignment Healthcare (ALHC) shares to be sold?

The filing lists an aggregate market value of $489,375 for the 22,500 Alignment Healthcare common shares. This value reflects the market pricing used in the notice for the planned Rule 144 sale on the Nasdaq Stock Market.

When were the Alignment Healthcare (ALHC) shares proposed for sale originally acquired?

The shares were acquired on February 7, 2024 through a stock award. The filing states they were granted under Alignment Healthcare’s 2021 Equity Incentive Plan, with 38,941 common shares acquired on that date as equity compensation.

When is the approximate sale date for the Alignment Healthcare (ALHC) Rule 144 shares?

The notice lists an approximate sale date of February 10, 2026. This date indicates when the holder expects to begin selling the 22,500 Alignment Healthcare common shares on the Nasdaq Stock Market, subject to market conditions and Rule 144 requirements.

How many Alignment Healthcare (ALHC) shares were outstanding in the Rule 144 notice?

The filing reports 200,091,742 common shares outstanding. This figure provides context for the size of the proposed 22,500-share Rule 144 sale relative to the company’s total equity base at the time referenced in the notice.

How were the Alignment Healthcare (ALHC) shares in the Rule 144 filing obtained?

The shares were obtained via a stock award granted on February 7, 2024. According to the notice, the award was made under Alignment Healthcare’s 2021 Equity Incentive Plan, and the issuer itself, Alignment Healthcare, Inc., was the source of the shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002006326
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alignment Healthcare, Inc.
SEC File Number	001-40295
Address of Issuer	1100 W. Town & Country Road Suite 1600 Orange CALIFORNIA 92868
Phone	844-310-2247
Name of Person for Whose Account the Securities are To Be Sold	Andreas Wagner
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chief Human Resources Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E-Trade Finance PO Box 101600 Arlington VA 22210-4600	22500	489375	200091742	02/10/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/07/2024	The Common Stock was acquired through the grant of a stock award on 02/07/2024 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			38941	02/07/2024	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Shares sold pursuant to a sale-to-cover transaction and does not represent a discretionary trade by the reporting person. Actual number of shares sold will be determined based on applicable tax withholding rates and stock price at the time of sale.
Date of Notice	02/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andreas Wagner
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)